NHMRC Boosts Global Medical Research Partnerships
The Australian government is investing nearly one million dollars into international medical research partnerships via the Horizon Europe scheme. A key project, MICRO-NEST, will investigate biological markers for autism in premature infants.
Why it matters
International research collaboration is critical for advancing medical diagnostics and improving support for neurodivergent individuals.
NHMRC is investing almost one million dollars for international collaborations in medical research through the NHRMC-Horizon Europe grant scheme .
This scheme enables Australian researchers to participate in leading international projects in health under Horizon Europe, supporting the creation and sharing of high-quality knowledge and technologies while promoting industrial competitiveness and economic growth.
In one of the funded projects, RMIT researchers will contribute to MICRO-NEST, an international collaboration using innovative approaches to identify biological markers associated with autism in children born prematurely. There is a significant unmet need for earlier autism diagnosis and improved therapeutic options, particularly for individuals with profound autism and high support needs, who often experience complex health challenges and require substantial lifelong support.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in